Your session is about to expire
← Back to Search
Treatment for Desmoplastic Small Round Cell Tumor
N/A
Recruiting
Led By Emily Slotkin, MD
Research Sponsored by Memorial Sloan Kettering Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 7 years
Awards & highlights
Summary
This study is a patient registry of people with Desmoplastic Small Round Cell Tumor (DSRCT). A patient registry is a collection of health information about a group of people, and it is usually focused on a specific diagnosis or disease. The purpose of this registry is to create a database- a collection of information-or better understanding DSRCT. Researchers will use the information from this database to learn more about DSRCT and for current and future research on DSRCT.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 7 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~7 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Registry to Collect Health Information About Desmoplastic Small Round Cell Tumor
Find a Location
Who is running the clinical trial?
Memorial Sloan Kettering Cancer CenterLead Sponsor
1,956 Previous Clinical Trials
595,306 Total Patients Enrolled
4 Trials studying Desmoplastic Small Round Cell Tumor
115 Patients Enrolled for Desmoplastic Small Round Cell Tumor
Emily Slotkin, MDPrincipal InvestigatorMemorial Sloan Kettering Cancer Center
8 Previous Clinical Trials
308 Total Patients Enrolled
4 Trials studying Desmoplastic Small Round Cell Tumor
115 Patients Enrolled for Desmoplastic Small Round Cell Tumor
Share this study with friends
Copy Link
Messenger